Occasionally, these antibodies interfere with fibrinogen binding to platelet GPIIb/IIIa or von Willebrand factor (vWF) binding to GPIb/IX receptors, resulting in severe bleeding phenotypes from acquired Glanzmann’s thrombasthenia or Bernard–Soulier syndrome, respectively [59]. Here, VWF is linked to Glanzmann thrombasthenia.